Cytomid-250 Flutamide Tablet

Cytomid-250 Flutamide Tablet Specification

Grade
Pharma

Usage
Hospital

Appearance
Tablets

Storage
Dry Place

Dosage
250mg

Cytomid-250 Flutamide Tablet Trade Information

Minimum Order Quantity
100 Strips

Supply Ability
5000 Strips Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Cytomid-250 Flutamide Tablet

Cytomid-250 Flutamide Tablet contains the active ingredient flutamide, which belongs to a class of medications known as antiandrogens. It is indicated for the treatment of prostate cancer, specifically in patients with advanced disease where surgical castration or other medical interventions are not appropriate or have failed. This works by blocking the action of androgens (male hormones), such as testosterone, on the prostate gland. Flutamide is primarily used in the treatment of prostate cancer, particularly in combination with other medications or treatments. Cytomid-250 Flutamide Tablet should be used with caution in patients with certain medical conditions, such as liver disease or glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Specification

Strength	250 mg
Packaging Size	10 x 10 Tablet
Form	Tablet
Prescription/Non prescription	Prescription
Manufacturer	Cipla
Composition	Flutamide IP
Brand	Cytomid-250

Advanced Therapy for Prostate Cancer

Cytomid-250 Flutamide Tablets are designed for the treatment of advanced prostate cancer, helping to block the effects of androgens that stimulate tumor growth. Their consistent efficacy and trusted pharmaceutical-grade formulation offer significant clinical value for hospitals and healthcare providers.

Quality Exporter and Wholesaler from India

Manufactured and exported from India, Cytomid-250 Flutamide Tablets are supplied by reputable wholesalers. Extensive quality checks and compliance with regulatory standards ensure these tablets deliver reliable therapeutic benefits wherever they are used.

Proper Storage for Prolonged Efficacy

To preserve the effectiveness of Cytomid-250 Flutamide Tablets, store them in a dry place away from direct sunlight and moisture. This ensures the product retains its potency throughout its shelf life, making it a dependable option for hospital pharmacies.

FAQ's of Cytomid-250 Flutamide Tablet:

Q: How should Cytomid-250 Flutamide Tablets be used in a clinical setting?

A: Cytomid-250 Flutamide Tablets are intended for oral use in hospital environments, primarily for patients with advanced prostate cancer. The prescribed dosage is typically 250mg, taken as directed by a healthcare professional.

Q: What is the primary benefit of using Cytomid-250 Flutamide Tablets?

A: The main benefit of Cytomid-250 is its ability to block androgen receptors, thereby slowing the growth of prostate cancer cells and enhancing patient outcomes during treatment.

Q: When should Cytomid-250 Flutamide Tablets be administered?

A: Administration timing and frequency depend on the oncologist's recommendation. Generally, the tablets are given at regular intervals each day to maintain consistent therapeutic levels.

Q: Where should Cytomid-250 Flutamide Tablets be stored for optimal effectiveness?

A: These tablets should be stored in a cool, dry place, protected from moisture and direct sunlight, to ensure their efficacy is preserved throughout their shelf life.

Q: What is the process of exporting Cytomid-250 Flutamide Tablets from India?

A: Cytomid-250 Flutamide Tablets are exported by licensed wholesalers in India, who comply with international regulatory and safety standards during packaging and shipment to ensure product integrity upon arrival.

Q: How does Cytomid-250 Flutamide Tablet benefit patients with prostate cancer?

A: By inhibiting androgen action, Cytomid-250 helps in managing cancer progression and provides significant symptom relief, supporting improved quality of life for prostate cancer patients.

Q: What is the recommended dosage of Cytomid-250 Flutamide Tablet and who sets it?

A: The usual dosage is 250mg per tablet, but the exact regimen is determined by a qualified healthcare provider based on individual patient assessments and clinical needs.